References
- Balasubramanian, G., et al., 2007. Screening the antiviral activity of Indian medicinal plants against white spot syndrome virus in shrimp. Aquaculture, 263 (1–4), 15–19.
- Ballantyne, B., et al., 1995. Fundamentals of toxicology. Gen AppTox. USA: McMillan Press.
- Boesche, R., 2003. Kautilya’s Arthasastra on war and diplomacy in ancient India. The journal of military history, 67 (1), 9–37.
- Borokini, T.I., and Omotayo, F.O., 2012. Photochemical and ethnobotanical study of some selected medicinal plants from Nigeria. Journal of Medicinal Plants Research, 6 (7), 1106–1118.
- Giddings, G., et al., 2000. Transgenic plants as factories for biopharmaceuticals. Nature biotechnology, 18 (11), 1151–1155.
- Gupta, V.K., and Sharma, B., 2017. Forensic applications of Indian traditional toxic plants and their constituents. Forensic research and criminology international journal, 4 (1), 27–32.
- Halstead B.W., 1988. Poisonous and venomous marine animals of the world. 2nd ed. Princeton NJ: The Darwin Press.
- Hasan, R.N., 2017. Antiviral activity of leaves extract of Lantana camara against the replication of A virus A/Puerto Rico/8/34 (PR8). Al-Anbar journal of veterinary science, 10 (1), 1-8.
- Kumar, S., et al., 2010. Euphorbia hirta: its chemistry, traditional and medicinal uses, and pharmacological activities. Pharmacognosy reviews, 4 (7), 58–61.
- Kumar, S., et al., 2020. Antiviral activity of belladonna during Japanese encephalitis virus infection via inhibition of microglia activation and inflammation leading to neuronal cell survival. ACS chemical neuroscience, 11 (21), 3683–3696.
- McMillan, M., and Thompson, J.C., 1979. An outbreak of suspected solanine poisoning in schoolboys: examination of criteria of solanine poisoning. Quarterly journal of medicine, 48, 227–443.
- Mukhtar, M., et al., 2008. Antiviral potentials of medicinal plants. Virus research, 131 (2), 111–120.
- Mutschler, E., et al., 2008. Arzneimittelwirkungen–Lehrbuch der Pharmakologie und Toxikologie. Endo-Praxis, 24 (03), 29–29.
- Pandey, A., et al., 2010. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. Human vaccine and immuno-therapeutics, 6 (2), 178–188.
- Patel , et al., 2013. Plant toxins: an overview. Research journal of pharmacology and pharmacodynamics, 5 (5), 283–288.
- Qiu, W., et al., 2017. The pandemic and its impacts. Health, Culture and Society, 9, 1–11.
- Raj, V., et al., 2021. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. International journal of biological macromolecules, 168, 474–485.
- Roy, S., et al., 2016. Evaluation of in vitro antiviral activity of Datura metel Linn. against rabies virus. Pharmacognosy research, 8 (4), 265–269.
- Sharma, A.D., and Kaur, I., 2020. Calotropin from milk of Calotropis gigantean a potent inhibitor of COVID 19 corona virus infection by molecular docking s Biomolecules,7,2-8.
- Singh, N.D., et al., 2007. Citrinin and endosulfan induced teratogenic effects in Wistar rats. Journal of applied toxicology, 27 (2), 143–151.
- Takouri, M.S.M., 2010. Historical essay: an Arabic surgeon, Ibn al Quff’s (1232–1286) account on surgical pain relief. Anesthecia: essay and researches, 4, 4–8.
- Tamilselvan, N., et al., 2014. A review on some poisonous plants and their medicinal values. Journal of acute disease, 3 (2), 85–89.
- Wink, M., and Van Wyk, B.E., 2008. Mind-altering and poisonous plants of the world. Vol. 464. Portland: Timber Press.
- Wink, M., 2000. Interference of alkaloids with neuroreceptors and ion channels. Studies in Natural Products Chemistry, 21, 3–122.
- Wink, M., 2007b. Importance of plant secondary metabolites for protection against insects and microbial infections. In: C. Carpinella and M. Rai, eds. Naturally occurring bioactive compounds: A new and safe alternative for control of pests and diseases, 3,251–268. Elesvier.
- Wink, M., 2010. Mode of action and toxicology of plant toxins and poisonous plants. Julius-Kühn-Archiv, 421, 93.
- Zhang, Q., et al., 2020a. Clinical trial analysis of 2019‐nCoV therapy registered in China. Journal of Medical Virology, 92, 540-545.